Market Research Reports and Industry Reports

Digital Pathology Market by Product (Scanners, Software), Type (Human, Animal Pathology), End User (Pharmaceutical Company, Hospital, Academic Institutions), Application (Teleconsultation, Drug Discovery) - Global Forecasts to 2021

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The digital pathology market is poised to reach USD 679.1 million by 2021 from USD 384.3 million in 2016, growing at a CAGR of 12.1% during the forecast period of 2016 to 2021.
 
 Digital pathology is an image-based information environment that allows for the management of information generated from a digital slide. The growth of the overall digital pathology market can be contributed to the rising prevalence of chronic diseases, utilization of digital pathology for drug discovery and companion diagnostics, and growing initiatives by government and industry player’s to enhance pathological services.
 
 The scanners segment is expected to account for the largest share of the digital pathology market, by product, in 2016. Digital pathology scanners create whole-slide images (WSI) from glass slides, converting the images into a digital form which helps to view, analyze, manage, share, and store them easily and efficiently, thus attributing to the largest share of the market. The human pathology segment is expected to account for the largest share of the digital pathology market, by type, in 2016. The large share of this segment is mainly due to increasing utilization of digital pathology for chronic disease diagnosis. The pharmaceutical & biotechnology companies and CROs is expected to account for the largest share of the global digital pathology market, end user, in 2016. Pharmaceutical and biotechnology companies are using digital pathology in drug discovery and companion diagnostics, thus contributing to the largest share of this market. The teleconsultation segment is estimated to account for the largest share of the digital pathology market, by application, in 2016. Increasing demand for pathology consultation in underserved areas through telepathology attributes to growth of this application.
 
 North America is expected to account for the largest share of the global digital pathology market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the presence of major pharmaceutical companies, increased cancer prevalence, presence of top market players, and growing government initiatives in Canada. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the growing chronic diseases prevalence, entry of top players and less stringent regulations in field of diagnostics.
 
 The digital pathology market witnesses high competitive intensity, as there are several big and small firms with similar product offerings. These companies adopt various strategies (partnerships, joint ventures, collaborations, expansions, new product launches, and acquisition) to increase their market shares and establish a stronger foothold in the global market. Prominent players in the global digital pathology market are Leica Biosystems Nussloch GMBH (Germany), Ventana Medical Systems, Inc.(U.S.), Hamamatsu Photonics K.K (Japan), 3D Histech Ltd(Hungary)., Philips Healthcare (Netherlands), Apollo Enterprise Imaging Corp.(U.S.), Xifin, Inc.(U.S.), Definiens AG (Germany), Visiopharm A/S (Denmark), Omnyx, LLC.(U.S.), Corista LLC (U.S.).
 
 Reasons to Buy the Report:
 

 The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
 
 The report provides insights on the following pointers:
 
 • Market Penetration: Comprehensive information on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on type, application, therapeutic area, and end user
 • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the digital pathology market
 • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various digital pathology products across regions.
 • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the digital pathology market
 • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital pathology market 

 1 INTRODUCTION 14
 1.1 OBJECTIVES OF THE STUDY 14
 1.2 MARKET DEFINITION 14
 1.3 MARKET SCOPE 15
 1.3.1 MARKETS COVERED 15
 1.3.2 YEARS CONSIDERED FOR THE STUDY 15
 1.4 CURRENCY 15
 1.5 LIMITATIONS 16
 1.6 STAKEHOLDERS 16
 2 RESEARCH METHODOLOGY 17
 2.1 RESEARCH METHODOLOGY STEPS 17
 2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 18
 2.2.1 SECONDARY RESEARCH 18
 2.2.2 PRIMARY RESEARCH 19
 2.2.2.1 Key data from primary sources 20
 2.2.2.2 Key insights from primary sources 21
 2.2.2.3 Key industry insights 22
 2.3 MARKET SIZE ESTIMATION METHODOLOGY 22
 2.4 RESEARCH DESIGN 24
 2.5 MARKET DATA VALIDATION AND TRIANGULATION 25
 2.6 ASSUMPTIONS FOR THE STUDY 25
 3 EXECUTIVE SUMMARY 26
 3.1 INTRODUCTION 26
 3.2 CONCLUSION 30
 4 PREMIUM INSIGHTS 31
 4.1 OVERVIEW OF THE DIGITAL PATHOLOGY MARKET 31
 4.2 GEOGRAPHIC ANALYSIS OF THE DIGITAL PATHOLOGY MARKET 32
 4.3 DIGITAL PATHOLOGY MARKET, BY TYPE 33
 4.4 DIGITAL PATHOLOGY MARKET, BY END USER 33
 4.5 DIGITAL PATHOLOGY MARKET, BY APPLICATION 34
 4.6 GEOGRAPHIC SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET 34
 5 MARKET OVERVIEW 35
 5.1 INTRODUCTION 36
 5.2 MARKET SEGMENTATION 36
 5.3 MARKET DYNAMICS 37
 5.3.1 DRIVERS 37
 5.3.1.1 Rising prevalence of cancer 37
 5.3.1.2 Increasing adoption of digital pathology to enhance lab efficiency 37
 5.3.1.3 Growing application of digital pathology in drug development and companion diagnostics 38
 5.3.1.4 Ease of consultation enabled by digital pathology 38
 5.3.1.5 Increasing initiatives by governments and industry players 39
 5.3.1.6 Increasing number of research projects establishing the efficacy of digital pathology 40
 5.3.2 RESTRAINTS 40
 5.3.2.1 High cost of digital pathology systems 40
 5.3.2.2 Regulatory concerns 40
 5.3.2.3 Lack of standard guidelines 40
 5.3.2.4 Reluctance among pathologists to adopt advanced technologies 41
 5.3.3 OPPORTUNITIES 41
 5.3.3.1 Digital pathology to help combat the shortage of pathologists 41
 5.3.3.2 Introduction of affordable scanners for private pathology practices 41
 5.3.3.3 Personalized medicine to open array of opportunities 41
 5.3.3.4 Integration of laboratory information systems (LIS) and digital pathology systems 42
 5.3.3.5 Increasing digital pathology initiatives in Asia 42
 5.4 REGULATORY IMPLICATIONS 42
 5.4.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA) 42
 5.4.2 FOOD AND DRUG ADMINISTRATION (FDA) 43
 5.4.3 CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA) 43
 6 DIGITAL PATHOLOGY MARKET, BY PRODUCT 44
 6.1 INTRODUCTION 45
 6.2 SCANNERS 46
 6.3 SOFTWARE 47
 6.4 COMMUNICATION SYSTEMS 48
 6.5 STORAGE SYSTEMS 50
 7 DIGITAL PATHOLOGY MARKET, BY TYPE 51
 7.1 INTRODUCTION 52
 7.2 HUMAN DIGITAL PATHOLOGY 53
 7.3 ANIMAL DIGITAL PATHOLOGY 54
 8 DIGITAL PATHOLOGY MARKET, BY END USER 55
 8.1 INTRODUCTION 56
 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CRO’S 57
 8.3 HOSPITALS AND REFERENCE LABORATORIES 58
 8.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 59
 9 DIGITAL PATHOLOGY MARKET, BY APPLICATION 60
 9.1 INTRODUCTION 61
 9.2 TELECONSULTATION 62
 9.3 DISEASE DIAGNOSIS 63
 9.4 DRUG DISCOVERY 64
 9.5 TRAINING AND EDUCATION 65
 10 GLOBAL DIGITAL PATHOLOGY MARKET, BY REGION 66
 10.1 INTRODUCTION 67
 10.2 NORTH AMERICA 68
 10.2.1 U.S. 72
 10.2.1.1 Favorable reimbursement scenario for digital pathology in the U.S. 72
 10.2.1.2 Rising cancer prevalence in the U.S. 72
 10.2.1.3 De Novo application by the FDA 72
 10.2.2 CANADA 74
 10.2.2.1 Growing need for quality cancer diagnosis in Canada 74
 10.2.2.2 Implementation of favorable initiatives by Canadian authorities 74
 10.3 EUROPE 76
 10.3.1 EU-5 80
 10.3.1.1 Initiatives adopted by NHS England promoting the adoption of digital pathology in the U.K. 80
 10.3.1.2 Technological developments in the U.K. market 80
 10.3.1.3 Organization of digital pathology-related conferences in the U.K. 81
 10.3.1.4 Organization of digital pathology-related conferences in Germany 81
 10.3.1.5 Successful digital pathology projects in Italy 82
 10.3.1.6 Active involvement of industry players to augment the demand for digital pathology in France 82
 10.3.1.7 Implementation of digital pathology-related projects to drive market growth in Spain 83
 10.3.2 ROE 85
 10.3.2.1 High cancer prevalence to boost market growth in Denmark 85
 10.3.2.2 Norway: Conferences and industry collaborations in the regional market 85
 10.3.2.3 Increased investments by government bodies in Sweden 86
 10.3.2.4 Digital pathology gaining momentum in the Netherlands 86
 10.4 ASIA-PACIFIC 88
 10.4.1 CHINA 92
 10.4.1.1 Industry initiatives to boost digital pathology market in China 92
 10.4.1.2 Favorable initiatives for the adoption of telepathology in China 92
 10.4.2 JAPAN 94
 10.4.2.1 Initiatives by NEC for cancer diagnosis to propel the market in Japan 94
 10.4.3 INDIA 96
 10.4.3.1 Focus of market players on India 96
 10.4.4 ROAPAC 98
 10.4.4.1 Cancer control initiatives in Australia 98
 10.4.4.2 Approvals for digital pathology solutions in South Korea, partnerships between local and global players 98
 10.5 ROW 100
 10.5.1 POTENTIAL FOR THE GROWTH OF DIGITAL PATHOLOGY IN AFRICA 100
 10.5.2 INCREASING FOCUS BY INDUSTRY PLAYERS AND ACADEMIC INSTITUTES ON THE BRAZILIAN MARKET 101
 10.5.3 INCREASING FOCUS OF INDUSTRY PLAYERS ON ORGANIC GROWTH STRATEGIES IN THE MIDDLE EAST 101
 11 COMPETITIVE LANDSCAPE 105
 11.1 OVERVIEW 105
 11.2 COMPETITIVE SITUATION AND TRENDS 105
 11.2.1 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 106
 11.2.2 PRODUCT LAUNCHES 108
 11.2.3 CLIENT ACQUISITIONS 110
 11.2.4 EXPANSIONS 111
 11.2.5 ACQUISITIONS 113
 11.2.6 OTHER STRATEGIES 114
 12 COMPANY PROFILES 116
 (Overview, Financial*, Products & Services, Strategy, and Developments)
 12.1 INTRODUCTION 116
 12.2 LEICA BIOSYSTEMS NUSSLOCH GMBH (SUBSIDIARY OF DANAHER CORP) 117
 12.3 VENTANA MEDICAL SYSTEMS, INC. (MEMBER OF ROCHE GROUP) 120
 12.4 HAMAMATSU PHOTONICS K.K. 123
 12.5 3DHISTECH LTD. 125
 12.6 PHILIPS HEALTHCARE 127
 12.7 APOLLO ENTERPRISE IMAGING CORP. (FORMERLY APOLLO PACS, INC.) 130
 12.8 XIFIN, INC. 132
 12.9 DEFINIENS AG 134
 12.10 VISIOPHARM A/S 136
 12.11 OMNYX, LLC (VENTURE BY GE HEALTHCARE AND UPMC) 138
 12.12 CORISTA LLC 140
 *Details might not be captured in case of unlisted companies.
  
 13 APPENDIX 141
 13.1 INSIGHTS OF INDUSTRY EXPERTS 141
 13.2 DISCUSSION GUIDE 142
 13.3 COMPANY DEVELOPMENTS (2013–2016) 145
 13.3.1 LEICA BIOSYSTEMS NUSSLOCH GMBH (A SUBSIDIARY OF DANAHER CORP) 145
 13.3.2 VENTANA MEDICAL SYSTEMS, INC. (A MEMBER OF ROCHE GROUP) 145
 13.3.3 PHILIPS HEALTHCARE 146
 13.3.4 APOLLO ENTERPRISE IMAGING CORP. (FORMERLY APOLLO PACS, INC.) 147
 13.3.5 DEFINIENS AG 147
 13.3.6 VISIOPHARM A/S 147
 13.3.7 OMNYX, LLC (A VENTURE BY GE HEALTHCARE AND UPMC) 148
 13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 149
 13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 151
 13.6 AVAILABLE CUSTOMIZATIONS 151
 13.7 RELATED REPORTS 152


List Of Tables

 TABLE 1 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 45
 TABLE 2 DIGITAL PATHOLOGY SCANNERS MARKET SIZE, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 46
 TABLE 3 DIGITAL PATHOLOGY SCANNERS VOLUME SOLD, BY REGION, 2014–2021 47
 TABLE 4 TYPES OF DIGITAL PATHOLOGY SOFTWARE 47
 TABLE 5 DIGITAL PATHOLOGY SOFTWARE MARKET SIZE, BY COUNTRY/REGION,
 2014–2021 (USD MILLION) 48
 TABLE 6 COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY 49
 TABLE 7 DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET SIZE,
 BY COUNTRY/REGION, 2014–2021 (USD MILLION) 49
 TABLE 8 DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET SIZE, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 50
 TABLE 9 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 52
 TABLE 10 HUMAN DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY/REGION,
 2014–2021 (USD MILLION) 53
 TABLE 11 ANIMAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY/ REGION,
 2014–2021 (USD MILLION) 54
 TABLE 12 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 56
 TABLE 13 GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES & CROS, BY COUNTRY/REGION,
 2014–2021 (USD MILLION) 57
 TABLE 14 GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR HOSPITALS AND REFERENCE LABORATORIES, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 58
 TABLE 15 GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 59
 TABLE 16 GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 61
 TABLE 17 GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR TELECONSULTATION,
 BY REGION/COUNTRY, 2014–2021 (USD MILLION) 62
 TABLE 18 GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR DISEASE DIAGNOSIS,
 BY COUNTRY/REGION, 2014–2021 (USD MILLION) 63
 TABLE 19 GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR DRUG DISCOVERY,
 BY COUNTRY/REGION, 2014–2021 (USD MILLION) 64
 TABLE 20 GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR TRAINING AND EDUCATION,
 BY COUNTRY/REGION, 2014–2021 (USD MILLION) 65
 TABLE 21 DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 68
 TABLE 22 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 70
 TABLE 23 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 70
 TABLE 24 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 70
 TABLE 25 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 71
 TABLE 26 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 71
 TABLE 27 U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 73
 TABLE 28 U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 73
 TABLE 29 U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 73
 TABLE 30 U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 74
 TABLE 31 CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 75
 TABLE 32 CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 75
 TABLE 33 CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 76
 TABLE 34 CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 76
 TABLE 35 EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY REGION,
 2014–2021 (USD MILLION) 78
 TABLE 36 EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 78
 TABLE 37 EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 78
 TABLE 38 EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 79
 TABLE 39 EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 79
 TABLE 40 EU-5: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 83
 TABLE 41 EU-5: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 84
 TABLE 42 EU-5: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 84
 TABLE 43 EU-5: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 84
 TABLE 44 ROE: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 86
 TABLE 45 ROE: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 87
 TABLE 46 ROE: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 87
 TABLE 47 ROE: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 87
 TABLE 48 ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY REGION,
 2014–2021 (USD MILLION) 90
 TABLE 49 ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 90
 TABLE 50 ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 91
 TABLE 51 ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 91
 TABLE 52 ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 91
 TABLE 53 CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 93
 TABLE 54 CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 93
 TABLE 55 CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 93
 TABLE 56 CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 94
 TABLE 57 JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 95
 TABLE 58 JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 95
 TABLE 59 JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 95
 TABLE 60 JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 96
 TABLE 61 INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 96
 TABLE 62 INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 97
 TABLE 63 INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 97
 TABLE 64 INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 97
 TABLE 65 ROAPAC: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 99
 TABLE 66 ROAPAC: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 99
 TABLE 67 ROAPAC: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 99
 TABLE 68 ROAPAC: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 100
 TABLE 69 ROW: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT,
 2014–2021 (USD MILLION) 103
 TABLE 70 ROW: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 103
 TABLE 71 ROW: DIGITAL PATHOLOGY MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 103
 TABLE 72 ROW: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 104
 TABLE 73 RECENT DEVELOPMENTS, 2013–2016 107
 TABLE 74 RECENT DEVELOPMENTS, 2013–2016 109
 TABLE 75 RECENT DEVELOPMENTS, 2013–2016 110
 TABLE 76 RECENT DEVELOPMENTS, 2013–2016 112
 TABLE 77 RECENT DEVELOPMENTS, 2013–2016 113
 TABLE 78 RECENT DEVELOPMENTS, 2013–2016 115


List Of Figures

 FIGURE 1 GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION 15
 FIGURE 2 GLOBAL DIGITAL PATHOLOGY MARKET: RESEARCH METHODOLOGY STEPS 17
 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 19
 FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 23
 FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 23
 FIGURE 6 DATA TRIANGULATION METHODOLOGY 25
 FIGURE 7 GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, BY PRODUCT (2016) 27
 FIGURE 8 GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, BY TYPE, 2016 VS. 2021 27
 FIGURE 9 GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, BY END USER, 2016 VS. 2021 28
 FIGURE 10 GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, BY APPLICATION (2016) 29
 FIGURE 11 ASIA-PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 30
 FIGURE 12 ATTRACTIVE OPPORTUNITIES IN THE DIGITAL PATHOLOGY MARKET 31
 FIGURE 13 NORTH AMERICA TO DOMINATE THE DIGITAL PATHOLOGY MARKET 32
 FIGURE 14 HUMAN PATHOLOGY SEGMENT TO GROW AT THE HIGHEST RATE 33
 FIGURE 15 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 33
 FIGURE 16 TELECONSULTATION SEGMENT WILL COMMAND THE LARGEST SHARE OF THE MARKET IN 2021 34
 FIGURE 17 ASIA-PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2016 TO 2021 34
 FIGURE 18 GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION 36
 FIGURE 19 DRIVERS, RESTRAINTS, AND OPPORTUNITIES 37
 FIGURE 20 DIGITAL PATHOLOGY MARKET SEGMENTATION, BY PRODUCT 45
 FIGURE 21 GLOBAL DIGITAL PATHOLOGY MARKET, BY TYPE, 2016–2021 52
 FIGURE 22 DIGITAL PATHOLOGY MARKET SEGMENTATION, BY END USER 56
 FIGURE 23 TELECONSULTATION TO COMMAND LARGEST SHARE OF THE DIGITAL PATHOLOGY MARKET, BY APPLICATION 61
 FIGURE 24 DIGITAL PATHOLOGY MARKET, BY REGION, 2016 67
 FIGURE 25 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT 69
 FIGURE 26 EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT 77
 FIGURE 27 ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SNAPSHOT 89
 FIGURE 28 ROW DIGITAL PATHOLOGY MARKET SNAPSHOT 102
 FIGURE 29 FIGURE: GROWTH STRATEGIES, BY COMPANY 105
 FIGURE 30 ACQUISITIONS & EXPANSIONS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS 106
 FIGURE 31 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS,
 BY COMPANY (2013–2016) 107
 FIGURE 32 PRODUCT LAUNCHES, BY COMPANY (2013–2016) 108
 FIGURE 33 CLIENT ACQUISITIONS, BY COMPANY (2013–2016) 110
 FIGURE 34 EXPANSIONS, BY COMPANY (2013–2016) 111
 FIGURE 35 ACQUISITIONS, BY COMPANY (2013–2016) 113
 FIGURE 36 OTHER STRATEGIES, BY COMPANY (2013–2016) 114
 FIGURE 37 PRODUCTS AND SERVICES OFFERED BY COMPANIES 116
 FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT 117
 FIGURE 39 ROCHE GROUP: COMPANY SNAPSHOT 120
 FIGURE 40 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT 123
 FIGURE 41 PHILIPS HEALTHCARE: COMPANY SNAPSHOT 127


Global Dental Digital X-ray Market Research Report 2016

2016 Global Alkaline Fuel Cell (AFC) Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Alkaline Fuel Cell (AFC) industry, focusing

USD 2850View Report

Global Digital Notes Market Research Report 2016

2016 Global Digital Notes Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Digital Notes industry, focusing on the main regions

USD 2850View Report

Global Digital Media Frame Sales Market Report 2016

Notes:Sales, means the sales volume of Digital Media FrameRevenue, means the sales value of Digital Media FrameThis report studies sales (consumption) of Digital Media Frame in Global market, especially in

USD 4000View Report

Global Digital Pathology Systems Sales Market Report 2016

Notes:Sales, means the sales volume of Digital Pathology SystemsRevenue, means the sales value of Digital Pathology SystemsThis report studies sales (consumption) of Digital Pathology Systems in Global market, especially in

USD 4000View Report

United States Digital Pathology Systems Market Report 2016

Notes:Sales, means the sales volume of Digital Pathology SystemsRevenue, means the sales value of Digital Pathology SystemsThis report studies sales (consumption) of Digital Pathology Systems in United States market, focuses

USD 3800View Report

Global Digital Pathology Analytics Market Research Report 2016

2016 Global Digital Pathology Analytics Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Digital Pathology Analytics industry, focusing on the

USD 2850View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 4650
  • Multi User Licence    $ 5650
  • Corporate Licence    $ 7150
  • Enterprise Wide Licence    $ 9000
$ 4650

Reports Details

Published Date : May 2016
No. of Pages :154
Country :Global
Category :Healthcare
Publisher :MarketsandMarkets
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment